Vehicle Control Clinical Trials
5 recruitingDrug
Phase 25
Showing 1–5 of 5 trials
Recruiting
Phase 2
A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE
Sjögren's Syndrome
Lubris Bio Pty Ltd80 enrolled6 locationsNCT07118241
Recruiting
Phase 2
Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease
Persistent Corneal Epithelial DefectCorneal Epithelial Disorders
University of Illinois at Chicago24 enrolled1 locationNCT06919081
Recruiting
Phase 2
A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CROSSOVER STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 μG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD)
Ocular Graft Versus Host Disease
Lubris Bio Pty Ltd15 enrolled3 locationsNCT07118254
Recruiting
Phase 2
A Study to Investigate the Safety and Efficacy of YY003 in Adults with Moderate to Severe Glabellar Lines
Moderate to Severe Glabellar Lines
Chongqing Claruvis Pharmaceutical Co., Ltd.174 enrolled3 locationsNCT06481475
Recruiting
Phase 2
Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa
Dystrophic Epidermolysis Bullosa
Anterogen Co., Ltd.6 enrolled1 locationNCT05157958